An essential role for Ran GTPase in epithelial ovarian cancer cell survival

被引:55
作者
Barres, Veronique [1 ]
Ouellet, Veronique [1 ]
Lafontaine, Julie [1 ]
Tonin, Patricia N. [2 ,3 ,4 ]
Provencher, Diane M. [1 ,5 ,6 ]
Mes-Masson, Anne-Marie [1 ,6 ]
机构
[1] CRCHUM, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada
[2] McGill Univ, Dept Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Human Genet, Montreal, PQ, Canada
[4] RI MUHC, Montreal, PQ H3G 1A4, Canada
[5] Univ Montreal, Dept Obstet Gynecol, Montreal, PQ, Canada
[6] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada
基金
加拿大健康研究院;
关键词
NUCLEAR-PROTEIN; APOPTOSIS; MEMBRANE; EXPRESSION; MIB-1; IDENTIFICATION; MECHANISM; TRANSPORT;
D O I
10.1186/1476-4598-9-272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: We previously identified that Ran protein, a member of the Ras GTPase family, is highly expressed in high grade and high stage serous epithelial ovarian cancers, and that its overexpression is associated with a poor prognosis. Ran is known to contribute to both nucleocytoplasmic transport and cell cycle progression, but its role in ovarian cancer is not well defined. Results: Using a lentivirus-based tetracycline-inducible shRNA approach, we show that downregulation of Ran expression in aggressive ovarian cancer cell lines affects cellular proliferation by inducing a caspase-3 associated apoptosis. Using a xenograft tumor assay, we demonstrate that depletion of Ran results in decreased tumorigenesis, and eventual tumor formation is associated with tumor cells that express Ran protein. Conclusion: Our results suggest a role for Ran in ovarian cancer cell survival and tumorigenicity and suggest that this critical GTPase may be suitable as a therapeutic target.
引用
收藏
页数:11
相关论文
共 37 条
  • [1] High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma
    Abe, Hideyuki
    Kamai, Takao
    Shirataki, Hiromichi
    Oyama, Tetsunari
    Arai, Kyoko
    Yoshida, Ken-ichiro
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) : 2391 - 2397
  • [2] Auersperg N, 1997, J CELL PHYSIOL, V173, P261, DOI 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO
  • [3] 2-G
  • [4] Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients
    Azuma, K
    Sasada, T
    Takedatsu, H
    Shomura, H
    Koga, M
    Maeda, Y
    Yao, A
    Hirai, T
    Takabayashi, A
    Shichijo, S
    Itoh, K
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (19) : 6695 - 6702
  • [5] A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
    Campeau, Eric
    Ruhl, Victoria E.
    Rodier, Francis
    Smith, Corey L.
    Rahmberg, Brittany L.
    Fuss, Jill O.
    Campisi, Judith
    Yaswen, Paul
    Cooper, Priscilla K.
    Kaufmann, Paul D.
    [J]. PLOS ONE, 2009, 4 (08):
  • [6] Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario
    Chipuk, J. E.
    Bouchier-Hayes, L.
    Green, D. R.
    [J]. CELL DEATH AND DIFFERENTIATION, 2006, 13 (08) : 1396 - 1402
  • [7] Genetic immune modulation of Ran GTPase against different microbial pathogens
    Chung, SW
    Huang, XY
    Song, JL
    Thomas, R
    Wong, PMC
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 3374 - 3383
  • [8] Spatial and temporal coordination of mitosis by Ran GTPase
    Clarke, Paul R.
    Zhang, Chuanmao
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (06) : 464 - 477
  • [9] Caspases: the executioners of apoptosis
    Cohen, GM
    [J]. BIOCHEMICAL JOURNAL, 1997, 326 : 1 - 16
  • [10] Now therapeutic agents in ovarian cancer
    Collinson, Fiona
    Jayson, Gordon
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2009, 21 (01) : 44 - 53